PCM
PRTA icon

Prelude Capital Management’s Prothena Corp PRTA Stock Holding History

Prelude Capital Management’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,600
Closed -$313K – 1491
2023
Q4 		$313K Buy
+8,600
New +$331K 0.02% 719
2019
Q3 		– Sell
-1,355
Closed -$14K – 1968
2019
Q2 		$14K Buy
+1,355
New +$13.9K ﹤0.01% 1338
2018
Q1 		– Sell
-98
Closed -$4K – 1676
2017
Q4 		$4K Sell
98
-88
-47% -$4.48K ﹤0.01% 1281
2017
Q3 		$12K Sell
186
-48
-21% -$2.94K ﹤0.01% 1406
2017
Q2 		$13K Buy
+234
New +$12.5K ﹤0.01% 1351

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Prelude Capital Management's PRTA Position: Q1 2024 in Review

Prelude Capital Management sold out of Prothena Corp (PRTA) in Q1 2024, closing a stake of 8,600 shares — an estimated $313K sold.

Prelude Capital Management first reported a position in PRTA in Q2 2017 and held it in 5 quarters. The position peaked at $313K in Q4 2023. 169 funds tracked by Wall St. Rank hold PRTA as of Q1 2024.

  • Prelude Capital Management reported no remaining Prothena Corp position as of Q1 2024 after selling out during the quarter.
  • Prelude Capital Management sold 8,600 Prothena Corp shares in Q1 2024, an estimated $313K.
  • Prelude Capital Management first reported a position in Prothena Corp in Q2 2017 and held it in 5 quarters.
  • Prelude Capital Management's Prothena Corp position peaked at $313K in Q4 2023.
  • 169 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2024.

Based on Prelude Capital Management's 13F filing for Q1 2024, filed 15 May 2024.